Soros Fund Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q2
Sell
-59,700
Closed -$632K 357
2014
Q1
$632K Buy
+59,700
New +$632K 0.01% 245